1300 856 695
+44 203 514 0688
1800 867 1390If you would like to submit a blog post for consideration, please email admin@healthcert.com
[3 min watch] Skin Cancer Update with Prof Giuseppe Argenziano [May 2019]
In this month’s skin cancer update video, Professor Giuseppe Argenziano talks about the role of Imiquimod in the treatment of primary melanoma. Using real patient case examples, Giuseppe describes the context in which Imiquimod can be utilised and the type of results physicians can expect.
He highlights that eight out of 10 patients using Imiquimod will see complete eradication of their primary lesion, and describes the recommended dose and usage for the treatment.
Watch the full skin cancer update now:
To learn more from Prof Giuseppe Argenziano:
More skin cancer updates from Prof Giuseppe Argenziano:
- Skin Cancer Update with Prof Giuseppe Argenziano [April 2019]: Special sites for melanocytic lesions
- Skin Cancer Update with Prof Giuseppe Argenziano [March 2019]: Atypical melanocytic lesions
- Skin Cancer Update with Prof Giuseppe Argenziano [February 2019]: When difficult cases fall outside the melanoma guidelines
